Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1995 Dec;74(6):580–583. doi: 10.1136/hrt.74.6.580

von Willebrand factor and its relevance to cardiovascular disorders.

G Y Lip 1, A D Blann 1
PMCID: PMC484109  PMID: 8541159

Abstract

In the past decade the importance of the vascular endothelium in cardiovascular pathophysiology has become more apparent. One substance that is synthesised by and stored in endothelial cells is von Willebrand factor (vWF). When released, vWF seems to mediate platelet aggregation and adhesion to the vascular endothelium. Because the release of vWF is increased when endothelial cells are damaged, vWF has been proposed as an indicator of endothelial disturbance or dysfunction. The availability of such an index of endothelial dysfunction may have clinical value, because measurement of such a marker can be a non-invasive way of assisting in diagnosis or as an indicator of disease progression. The known association between vWF, thrombogenesis, and atherosclerotic vascular disease also suggests that high concentrations of vWF may be an indirect indicator of atherosclerosis and/or thrombosis. In addition, high vWF concentrations have prognostic implications in patients with ischaemic heart disease and peripheral vascular disease.

Full text

PDF
580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreotti F., Hackett D. R., Haider A. W., Roncaglioni M. C., Davies G. J., Beacham J. L., Kluft C., Maseri A. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction. Thromb Haemost. 1992 Dec 7;68(6):678–682. [PubMed] [Google Scholar]
  2. Blann A. D., Maxwell S. R., Burrows G., Miller J. P. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease. Atherosclerosis. 1995 Aug;116(2):191–198. doi: 10.1016/0021-9150(95)05541-4. [DOI] [PubMed] [Google Scholar]
  3. Blann A. D., Naqvi T., Waite M., McCollum C. N. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993 Apr;7(2):107–111. [PubMed] [Google Scholar]
  4. Blann A. D. von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J Rheumatol. 1993 Sep;20(9):1469–1471. [PubMed] [Google Scholar]
  5. Blann A., Midgley H., Burrows G., Maxwell S., Utting S., Davies M., Waite M., McCollum C. Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coron Artery Dis. 1993 Oct;4(10):905–910. doi: 10.1097/00019501-199310000-00010. [DOI] [PubMed] [Google Scholar]
  6. Blann A. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci. 1993 Jun;50(2):125–134. [PubMed] [Google Scholar]
  7. Boneu B., Abbal M., Plante J., Bierme R. Letter: Factor-VIII complex and endothelial damage. Lancet. 1975 Jun 28;1(7922):1430–1430. doi: 10.1016/s0140-6736(75)92650-1. [DOI] [PubMed] [Google Scholar]
  8. Cortellaro M., Boschetti C., Cofrancesco E., Zanussi C., Catalano M., de Gaetano G., Gabrielli L., Lombardi B., Specchia G., Tavazzi L. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb. 1992 Sep;12(9):1063–1070. doi: 10.1161/01.atv.12.9.1063. [DOI] [PubMed] [Google Scholar]
  9. Davies S. W., Ranjadayalan K., Wickens D. G., Dormandy T. L., Timmis A. D. Lipid peroxidation associated with successful thrombolysis. Lancet. 1990 Mar 31;335(8692):741–743. doi: 10.1016/0140-6736(90)90866-4. [DOI] [PubMed] [Google Scholar]
  10. Deng L., Bremme K., Hansson L. O., Blombäck M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol. 1994 Dec;84(6):941–945. [PubMed] [Google Scholar]
  11. Fowkes F. G., Lowe G. D., Housley E., Rattray A., Rumley A., Elton R. A., MacGregor I. R., Dawes J. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 1993 Jul 10;342(8863):84–86. doi: 10.1016/0140-6736(93)91288-w. [DOI] [PubMed] [Google Scholar]
  12. Geggel R. L., Carvalho A. C., Hoyer L. W., Reid L. M. von Willebrand factor abnormalities in primary pulmonary hypertension. Am Rev Respir Dis. 1987 Feb;135(2):294–299. doi: 10.1164/arrd.1987.135.2.294. [DOI] [PubMed] [Google Scholar]
  13. Jansson J. H., Nilsson T. K., Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991 Nov;66(5):351–355. doi: 10.1136/hrt.66.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lip G. Y., Lowe G. D., Metcalfe M. J., Rumley A., Dunn F. G. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol. 1995 Sep 1;76(7):453–458. doi: 10.1016/s0002-9149(99)80129-5. [DOI] [PubMed] [Google Scholar]
  15. Lip G. Y., Lowe G. D., Metcalfe M. J., Rumley A., Dunn F. G. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Int J Cardiol. 1995 Jun 2;50(1):31–42. doi: 10.1016/0167-5273(95)02327-s. [DOI] [PubMed] [Google Scholar]
  16. Lip G. Y., Lowe G. D., Rumley A., Dunn F. G. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J. 1995 Jun;73(6):527–533. doi: 10.1136/hrt.73.6.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Liu L., Lin Z., Shen Z. Changes of von Willebrand factor and antithrombin III levels in acute stroke: difference between thrombotic and haemorrhagic stroke. Thromb Res. 1993 Nov 15;72(4):353–358. doi: 10.1016/0049-3848(93)90145-e. [DOI] [PubMed] [Google Scholar]
  18. Lüscher T. F. The endothelium. Target and promoter of hypertension? Hypertension. 1990 May;15(5):482–485. doi: 10.1161/01.hyp.15.5.482. [DOI] [PubMed] [Google Scholar]
  19. Meade T. W., Cooper J. A., Stirling Y., Howarth D. J., Ruddock V., Miller G. J. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994 Nov;88(3):601–607. doi: 10.1111/j.1365-2141.1994.tb05079.x. [DOI] [PubMed] [Google Scholar]
  20. Nilsson T., Mellbring G., Hedner U. Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis. Acta Chir Scand. 1986 May;152:347–349. [PubMed] [Google Scholar]
  21. Pedrinelli R., Giampietro O., Carmassi F., Melillo E., Dell'Omo G., Catapano G., Matteucci E., Talarico L., Morale M., De Negri F. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994 Jul 2;344(8914):14–18. doi: 10.1016/s0140-6736(94)91047-2. [DOI] [PubMed] [Google Scholar]
  22. Smith F. B., Lowe G. D., Fowkes F. G., Rumley A., Rumley A. G., Donnan P. T., Housley E. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis. 1993 Sep;102(2):155–162. doi: 10.1016/0021-9150(93)90157-p. [DOI] [PubMed] [Google Scholar]
  23. Uchiyama S., Takeuchi M., Osawa M., Kobayashi I., Maruyama S., Aosaki M., Hirosawa K. Platelet function tests in thrombotic cerebrovascular disorders. Stroke. 1983 Jul-Aug;14(4):511–517. doi: 10.1161/01.str.14.4.511. [DOI] [PubMed] [Google Scholar]
  24. Vaziri N. D., Smith D. H., Winer R. L., Weber M. A., Gonzales E. C., Neutel J. M. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J Am Soc Nephrol. 1993 Aug;4(2):222–228. doi: 10.1681/ASN.V42222. [DOI] [PubMed] [Google Scholar]
  25. Wahlberg T. B., Blombäck M., Overmark I. Blood coagulation studies in 45 patients with ischemic cerebrovascular disease and 44 patients with venous thromboembolic disease. Acta Med Scand. 1980;207(5):385–390. doi: 10.1111/j.0954-6820.1980.tb09743.x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES